Skip to content

LBRX LBRX Return on equity

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
38.8%+7.3pp
Alkermes logo
AlkermesALKS
9.4%-16.1pp
Alto Neuroscience logo
Alto NeuroscienceANRO
-38.9%+0.9pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
100.7%+60.3pp
Opko Health logo
Opko HealthOPK
-16.9%-21.7pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
37.3%+0.1pp

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+159%
Enterprise value$556.86M

Returns & leverage

See full
Debt / equity
Current ratio35.7×